Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation.
Trimetazidine, a piperazine derivative used as an anti-anginal agent, improves myocardial glucose utilization through inhibition of fatty acid metabolism. The present study was designed to investigate whether trimetazidine has the protective effects against smoking-induced left ventricular remodelin...
Guardado en:
Autores principales: | Xiang Zhou, Chao Li, Weiting Xu, Jianchang Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8074a9dd820f45b69f4d854ef0ada5cd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Left ventricular remodeling patterns in children with metabolic syndrome
por: Veronica ESANU, et al.
Publicado: (2020) -
Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction
por: Yusuke Adachi, et al.
Publicado: (2021) -
Circulating biomarkers as predictors of left ventricular remodeling after myocardial infarction
por: Michał Węgiel, et al.
Publicado: (2021) -
Patterns of left ventricular remodeling among patients with essential and secondary hypertension
por: Radulescu,Dan, et al.
Publicado: (2013) -
Effects of triptolide and methotrexate nanosuspensions on left ventricular remodeling in autoimmune myocarditis rats
por: Li W, et al.
Publicado: (2019)